20 results on '"A. Kępa"'
Search Results
2. Assessment of sensitivity of selected Candida strains on antimicrobial photodynamic therapy using diode laser 635 nm and toluidine blue – In vitro research
- Author
-
Aleksandra Kawczyk-Krupka, Grzegorz Cieślar, Łukasz Gilowski, Natalia Stefanik, Rafał Wiench, Dariusz Skaba, and Małgorzata Kępa
- Subjects
medicine.medical_treatment ,030303 biophysics ,Biophysics ,Photodynamic therapy ,Microbial Sensitivity Tests ,Dermatology ,Methylmethacrylate ,law.invention ,Microbiology ,030207 dermatology & venereal diseases ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,law ,medicine ,Humans ,Pharmacology (medical) ,Tolonium Chloride ,Toluidine ,Candida albicans ,Dentures ,Candida ,Colony-forming unit ,0303 health sciences ,Photosensitizing Agents ,Dose-Response Relationship, Drug ,biology ,Antimicrobial ,biology.organism_classification ,Laser ,Corpus albicans ,In vitro ,Photochemotherapy ,Oncology ,chemistry ,Biofilms ,Lasers, Semiconductor - Abstract
Background Photodynamic therapy is believed to be a promising treatment for Candida infections. This study evaluated the efficacy of antimicrobial photodynamic therapy (aPDT) using the 635 nm diode laser light and toluidine blue (TB) in the elimination of selected Candida species cultured on acrylic surface. Methods 108 acrylic plates (Methyl Methacrylate Polymer, routinely used for the production of prosthetic dentures) were placed in three sterile Petri dishes and poured with prepared suspensions of Candida strains: C. albicans, C. glabrata, and C. krusei. After all procedures of fungi incubation, fungal biofilm was visible on the plates’ surfaces. The acrylic plates were divided into nine study groups (B) and nine control groups (K) for further experiments. In the study groups, the acrylic plates with fungal biofilm were immersed in TB and afterwards laser irradiation was applicated with different exposure parameters (groups: B1 – 400 mW, 24 J/cm2, 30 s; B2 – 300 mW, 18 J/cm2, 30 s; B3 – 200 mW, 12 J/cm2, 30 s) separately for each Candida species. The control groups contained following parameters: no exposure to laser light or TB, treatment only with TB without laser irradiation, or only laser irradiation without previous immersion in TB. Calculations of colony forming units (CFUs) were conducted by using aCOlyte (Synbiosis). Differences in CFUs were analyzed by the Wilcoxon test. Results In all study groups, the reduction in CFUs was statistically significant. The differences in CFUs before and after intervention were insignificant. The K3 C.a. control group showed a statistical reduction of Candida albicans after laser irradiation. Conclusion Our study confirmed the efficacy of aPDT against C. albicans, C. glabrata and C. krusei being dependent on the laser parameters and the type of fungus. The advantage of this study is the validation of aPDT effectiveness in in vitro studies to transpose this data into future clinical trials using photodynamic therapy in the treatment of oral candidiasis.
- Published
- 2019
3. Prevalence of diabetic and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities
- Author
-
H Appeltants, C Boesch, I Cromarty, D Carretta, S Romanov, U Windstetter, F Mibach, Jens Refsgaard, S Lebedev, F Proietti, M Y Tamimi, M C Gamboa, M Novikova, E Prada, K H Sim, E Messas, E Zherlitsyna, A Kalampalikis, N Nevolina, N Trocan, J Cohen, G Szto, R Gilabert Gómez, M Omelchenko, A Pinzani, D Goodwin, J Umaran Sánchez, Kim Fox, S H Dong, K Kronberg, E Castillo Lueña, T Ignatieva, S Joubert, C Macchi, S Lee, S Eidelman, F Alizon, S Chandra, M Akbar, D M Colquhoun, G Yanes Bowden, J de Juan Baguda, M Sebastian, C Wernham, K Miedema, R La Greca, C Morton, B S Jheeta, A C Tran, T Q Do, O Rodrigues, J Yan, S H Kim, R Jurgaitienė, Jean-Claude Tardif, R Baleón, D Hay, V Hennebelle, F Fazekas, R Davies, P Gratia, L Sorodoc, S Y Wu, C Martínez Sánchez, L Lopes Antunes, T H T Pham, I Suliman, M J Gómez Martinez, A Pernat, S H Hur, M Alanazy, L Zhabina, M Stanley, J Rogers, Y J Kim, S Geffroy, L K Andersen, S Coman, V Pedrosa del Moral, Y Garaud, J Krupicka, O Dzhkha, C Paul, M Jeżewska, B Mahler Mioto, V Abduvalieva, P Morra, L Kucheryava, C La Rosa, B Chan, M Wrębiak-Trznadel, A Kozlowski, M Sharif, L López Barreiro, V Kolesnikov, M Lawrence, A Tucker, C Okawabata, B La Hay, E Sadauskienė, B K Nguyen, L Bui, A Said, M E Ruíz Esparza, R K Saran, M S C Ho, E Homs Espinach, J R Romo Santana, J Forte De Carvalho, I Pattison, H H Phan, L Baleeva, L Kisiel, A López Granados, C Raters, F Paganelli, R Haberl, A P T Wong, D Xu, R Jagathesan, L Grekhova, H Stursova, Q B Truong, P Raymond, Y Sosnova, N H Khong, J Zarauza Navarro, C Florescu, L Gorshkova, N Saaidin, E Gordillo Higuero, L Davin, I Budanova, C Lavicka, L Gruznykh, P Bogdański, A Dufka, I Arroja, H A R Tahir, G Wilson, G Kolios, S J Yoon, Simon Cattan, K Berdnik, A Serrano, B Sievers, A Rodríguez Almodóvar, L A Holden, F O'Reilly, D Verleyen, H Hafez, K Nehrig, S M Kang, S Berrisch-Rahmel, E Meyer-Michael, P Samama, L Soares, A K Nguyen, F Tuktarova, C Weytjens, E Sandoval Rodriguez, J Cheng, F M Villasenor, João Morais, B Sullivan, R Zimoląg, Albert V. Smith, S F Ding, J C Louchart, G Guardigli, R Furtak, P Azzolini, S Chushak, J L Delgado Prieto, S Kornienko, K K Sia, J H Shin, F Baylac Domengetroy, P Błaszczak, M Saade, N Černič-Šuligoj, K Coetzee, A Kadleckova, V Scollo, O Larina, R Pal, M M Singh, N Nosova, R Burns, B S Yoo, O Gukov, F Massari, V Antia, A Brattström, G Holt, M Scherbak, V Firastrau, Y J Li, E Mikhailova, L Machado Cesar, C García García, J Pjontek, C Everton Biglow, G Pes, C Brown, A Bumbu, S Felis, R Bosch, M Lazaro, Luigi Tavazzi, R Engel, I Romeo Castillejo, Y S Byun, F Matias, I Grushetskaya, C Mestre-Fernandes, T Kheliya, S Schlesingerova, G Theodorakis, I Tsamopoulos, R Pedretti, A Puente Barragán, M P Vo, B Lammens, T Carruthers, J S Bhatt, A Khodanov, N Pasechnaya, I Petrova, G Boutros, I A Khan, E Le Moal, D Garofalo, H R Malaterre, A Bahal, J F Martínez González, H N Dinh, N V Pham, C Barjhoux, I Gilmour, C Soriano Navarro, O D Chioncel, K Tóth, N Borodina, P Khanoyan, B Sevilla Toral, H H Kim, C M A Bui, C Dernedde, N Eliseeva, M Galinier, E Kosachek, M M Doohan, L Potapska, M Tennekoon, R Nourallah, L Perez De Isla, K H Chee, E Panova, D M Walker, G Glanowska, G Hua, A Silvestre, W Wang, Matthew A. Brown, B Luke, G Jarosiński, R Davis, S Cleron, C Liatas, I Orestis, M Dereń, J Sudnik, S X Zhou, J Fuertes Alonso, O Baranova, S Mingalaeva, T N Vo, K A Ngo, J A Rodríguez Fernández, R Ishmael, G Bode, K K Chan, G Al Radaideh, S Ramphall, H D Theron, V Montagud Saavedra, A Yusuf, G F Mazzanti Mignaqui, L Evtukhova, J Lorenc, D Beacock, O B Šlapikienė, F Alitto, J N Poujois, B Berzal Martín, M Felbermayer, V Mallamaci, T Spitsina, R Ramachandran, A Jánosi, V Dženkevičiūtė, S Gillam, V Joulie, G Esna Ashari, R Henry, E Durand, A Alam, V Fourchard, H Dreycopp, R Fressonnet, C Camossa, O Jerzykowska, M Castrucci, G Sinicropi, B K Goyal, V Vasylenko, R Grogono, M Partington, B Vaquette, R Blindt, Mª T Moreno Casquete, V Kukaleva, W Streb, P F Clavette, M Pérez Paredes, V Hadjiivanov, C Bundy, D E Manyari, A Wassef, J Kuchar, W Nisker, P S Bath, S Panpunnung, G H Choo, Datshana P Naidoo, Y Pavlova, R McManus, N Brand, E Davies, L Prunier, A Schenowitz, P Sternthal, T Sinotova, J Martínez Florez, R Sykulski, J Pinar Sopena, M Balbi, Y Pesant, D A Playford, C Villar Mariscal, F Redding Escalante, W Wongcharoen, O Grechishkina, A Girão, M Speth-Nitschke, K A Mahendran, A Bianco, A Vadavi, G Singh, L Petoin Peuch, L Sukhanova, A Y Y Fong, J L Vega Barbado, A Dzien, S Honorat, G Ansalone, G Kamensky, G McLaren, T B Kim, I Bratu, R Fillet, V Rogozhyna, L Nagy, M Malgina, M A Sheikh Abdul Kader, Z C Li, L Rotaru H Rus, D Adamczyk-Kot, J Estrella, S Serrano García, P Farto E Abreu, D Mescharekova, Su Thillai Vallal, P Seal, S Möller, A Cziráki, T T H Ta, S Davies, H Ge, M Arafah, M Ovize, A Olszewski, V Aboyans, C Roche, F Al Tamimi, L Popova, V Kazachkova, R Rennert, J Aubry, G Bourgeois, J Mackrell, F Al Kandari, N Reifart, J Bérubé, W H J Hutse, O Lysunets, I Butkuvienė, J Cotroneo, J Gdalia, J Dalle Mule, R Santos, B Singh, H Mohammed, A Birkenhagen, T Chiscaneanu, H Sullivan, Jacob A. Udell, N Bolotova, A Jankowska, M Skonieczny, B S K Ch'ng, O Aiyegbayo, S Ciaroni, N Lago, S R Coimbra, R Ellis, B K Koo, S Rostik, P Jacquier, A Conradie, N Biryukova, M Ayche, A Khripun, B Peperstraete, E Velasco Espejo-Saavedra, G Cunliffe, G Grollier, C Ceraulo, T L To, Q H Tran, M Anscombe, R Jordan, I Czuriga, P Haimes, R Ancín Viguiristi, H Q Zhang, C A Chételat, A Rafter, E Rinkūnienė, K Yang, W Gao, J Pearce, L C Fernández Léoz, L Gareeva, R Fernández Alvarez, G Verret, P Astrakhantseva, C M Chu, L Murphy, P A Do, J L Liu, A Clifford, K Woollard, N Dmitrieva, N Lousada, R Díaz Juárez, N Semenova, T Fesenko, F Henschel, R Amini, G Matuszewska, R Christodorescu, J Varaldi, S Varughese, V Lafarenko, A Ashford, J L Colomer Martín, S Assouline, H Noor Hasni, A Weatherup, T Forster, R Kaserbacher, I Caldwell, N Arabadzhi, Emmanuel Sorbets, A Rink, E C Rueda Calle, J M Stordeur, P West, V C Do, Béla Merkely, J Antunes, U Altmann, S Magheru, B Bachmann, W Parkar, M de los Reyes López, M Wazana, A Frattola, M Mospan, V Koval, E Giusti Rossi, J Vasconcelos, K B Do, A Ogorodnichuk, D Lighezan, G Mentz, J M Cherry, P Pouderou, M Moretti, C M Spinu, Emmanuelle Vidal-Petiot, N Kupstytė, P Jourdain, V Voronina, O Varezhnikova, S Williams, H AlFaleh, R Lew, P Hildebrant, J Drozd, G Muscio, T H Ashton, A Achilli, J Harinasuta, T Ghose, G Walawski, Y Arkhipova, M Alves Costa, B Day, A Suntinger, A Singh, P Sheringham, A Vázquez García, J Taggeselle, J T Dong, T H Goh, G Rojas, R Schultz, A Ballet, O Likhobabina, Z M Qian, S Sandoval Navarrete, D Manzi, S Langridge, W Haerer, C K Abdullah, L Hay, Á Herdade, A Gałuszka-Bilińska, F Biausque, V M Lai, D S Eccleston, L Nikolaeva, P Kalaras, J Martínez Redding, N P H Tran, B Wauer, Philippe Gabriel Steg, B Etcheverry, J Navarro Manchón, R Augarde, C Dixon, M Y Chen, J L Gleizes, S Pustovit, J L Farges, S Cox, G Manchet, K Shein, L Parker, C C Ang, O Sinyukova, V Veth, A Kurekhyan, N Cindea Nica, N Wittlich, J Al Yazeedi, A Pucheu, V Elliott, J Bories, K Alford, M F Ferrão E Vasconcelos, A Adamkiewicz-Piejko, R Cervenak, J F Beltrame, A Castro, L Safonova, G Koutsimpanis, C de Brito Vianna, R Wysocki, V Ginzburg, J Hernández Afonso, A Ihonor, O Golubeva, M Karachaliou, S Kleta, D d'Este, Gustavs Latkovskis, F Jäger, E Gamzatov, Y Kozhelenko, J Lippai, T T L Ong, S J Ge, A Hersi, K Kyd, S Mingam, V Yordanova, L Bardachenko, E Mozerova, S W Liu, J Zdrojewska, E Chung, M Leclair, M Nazir, S Zarechnova, A Rahman, M Sołtysiak, B Maguire, F Moreira Pinto, R Fathi, E Prieto Moriche, C Priftis, P Heno, N Sytilina, A Pladys, S Shimonenko, P Keller, J F Junior, G Amiel Oster Sauvinet, J P Kanner, L Tkachenko, J Dalal, A Liston, D Herrera Fernández, J L Bonnet, A Chirivella González, R P Shah, F A Reyes Cisneros, C Avgerinos, P Ravoala, V Albero Martínez, G Suarez, V Jouve, A Frankiewicz, A Lindsay, A De Meester, H Dau, M Pornin, J Álvarez Gil, J Murin, T Hodac, J J Gómez Barrado, Y J Wu, S Jean, P Hilti, A Dayani, R Steponėnienė, G A Somsen, H Zhang, J Moore, P Tarenidis, T H Nguyen, M Maliszewski, L Voloshyna, S Novo, A Phrommintikul, I Shanina, Roberto Ferrari, P Franklin, C Turner, W Boonyapisit, F Sepulcri, P Vandergoten, J Carvalho, J Halcox, V Rotenberger, J F Baril, M Turiel, P Shiels, P Painsipp, S Reis Monteiro, T Honsig, V Vivekaphirat, J Ardill, P Brodzicki, A Khalifa, H Audibert, T Wettstein, F Auhser, D Ezekiel, D Pella, E Simarro Martín-Ambrioso, H S Seo, J A Núñez Gamero, Gabriel Steg, M Orbán, S Bykovskaya, W Gadziński, N Rozkova, G H M Vawda, R A Motyer, B Limeres González, E Fernandez Valadez, Riyaz S. Patel, I Shaikh, E Ziak, A Estriga, P Dodemant, Dragos Vinereanu, W Miao, L Marullo, F MacNamara, S K Tan, N Giacomantonio, A Leherissier, H W Li, Arpana Agrawal, Y Moreau, F David, S K Ma, A N Jamaluddin, E Alegría Ezquerra, Scalzo, M C Ta, T T Nguyen, A Sudre, R Gupta, H Lagioia, M Haiba, P Kohan, M Szentivanyi, T Dmitrieva, N Vechtomova, C Vuille, R G Schena, P Navratil, O Tsygankov, L Saaby, P Lefebvre, S King Wong, S Maheas Morlet, N H Pham, P Bonnet, S Modi, L Gaspar, M Karlicek, S Pallie, H T Pham, S Abele, N Bizyaeva, L Facila Rubio, N Meneveau, G Poluyanova, J Calaça, S Orazi, M Emonts, A Yusufali, V Sprott, Z Vazhdaeva, M R Conte, E Bulakhova, K Giokoglu, E Page, E Kotova, G Maragoni, C Jerjes Sánchez, T Kiver, M Brunehaut Petaut, A Nagy, P Singer, Zs Sziegl, B Fontanet, S Strange, A Watson, J Föchterle, Janet A. Dunn, R Šlapikas, M Stikhurova, S Salimova, J Volmar, E Otero Chulian, S Hutchinson, R Koller, X Bonnaud, E Peris Domingo, F Marín Ortuño, E Galve Basilio, S Bongo, L Payot, C Miller, A Samothrakitis, L Silva Melchor, K Orzechowski, W Hofer, L V Nguyen, R Oliver, K T Jung, J Robb, D Sobczyk, J Muller, A Tomatti, M Gruchała, C Bradshaw, D Richmond, E Mineeva, E Smirnova, A Idrissi-Sbai, H Vial, R Balai, I Kiseleva, H Jones, M Gibbs, D Ohlmeyer, Y Al Wahshi, V d’Alessandro, S Pérez Ibiricu, V Zachos, A Chernozemova, D R Spink, J Schneider, A M Peset Cubero, M Irurita Latasa, M Migliore, G Perna, E Daniels, M H Tay, N Z Khiew, I Soin, F Bernasconi, T Garban, F Omardeen, O Rodina, L Kanagaratnam, I Blum-Decary, A Jaussi, D Romero Alvira, D Vermander, N Kanumilli, M A Romero Maldonado, M Fernández-Valls Gómez, H Tran, T P Nguyen, H Omar, R S Collette, B Kisjós, H Krause-Allmendinger, J Silva E Sá, H Topf, F Panetta, T C Do, G Roul, J Leso, A Lacroix, M Fic, C Hart, R Chan, L Lema, Y Polyanskaya, R Howlett, Lesley J. Burgess, X P Chen, Hywel C Williams, V T Le, N Gurianova, R Duchowska, V P Nair, D Mitropoulos, A Allcock, T T H Bui, M Golub, E Yakovenko, M Perry, F Belcastro, K Svolis, B H R Forge, F Fernández de la Cigoña, N Murga Eizagaechevarría, G Mariano Pêgo, V Mincheva, T N Nguyen, J Moyal, M Wei, H Vinhas, A Batalla Celorio, C Romero Menor, S Rahman, N Hassler jun, F Duclos, K Ladha, A Ordóñez España, B C Chang, R Cortés Sánchez, G Lafrance, I Mihailova, Y Riou, I Pashentseva, S Tantillo, U Casas Juarezy, Ian B. Wilkinson, MJuneja, Q L Liu, M Baquero Alonso, P Kirmond, A Stevens, T Bouvy, P Casas Giménez, G Kassianos, P Kohler, T Rundell, J A Romero Hinojosa, T Sagastagoitia Gorostiza, M A Bennouna, A Hourany, F Thoin, G Steurer, V Batushkin, L Kolevatova, A Földi, G Sabe-Affaki, J T M Geraedts, I Illushechkin, T Korotich, W Manlay, B Merian, G Morrison, Y Wang, G Solache, P Magnus, A Lugin, S Tereshko, Jorge Escobedo, D Sharp, A Thelemann, J Gold, M Catarino Carvalho, P Lang, B Hermellin, B Doucet, A Martín Santana, E Foltzer, J Mora Robles, A I Bakbak, G Stanciulescu, L Baurenski, O Demina, G Lalljie, N Shmakova, R Vicente Amato, N Q Nguyen, S Kimmel, J-M Grégoire, F Tumarov, R Cue Carpio, S Nikishina, A Mukhtar, J Rueda Soriano, M Gnädinger, Michal Tendera, P Raska, S Cicek-Hartvig, E Potapova, A Melero Pita, P Ormiston, L Pastor Torres, R Shaw, M S Chenniappan, T Guo, L Zharikova, R Amoretti, J Janssen, G Kositsina, S Rajendran, N Atamanchuk, V Plastiras, T Kiernan, M H Pham, V M J Jelinek, J Dalrymple, S Van de Walle, M Goethals, I Stelmakh, S Cantabrana Miguel, L Hurlock-Clarke, C Ferreyra Solorio, J Alcaravela, H H Chuang, C Statescu, T Ługowski, B G Vanhauwaert, E London, G Z Pan, Z Özkan-Rashed, F Fellous, O Fillipova, K Ashmak, L Sargento, N Starostina, J A Ortiz de Murua López, H Thomas, T Gerasimova, L H Gowdak, S Perings, E Gaxiola, K Walcher, O Pogrebna, T Stasiuk, J Bell P McNaught, J Upton, G Scott, P Rossi Sevillano, A Gillet, T K L Nguyen, L E Manautou, L Kardashevskaya, A B Syed, F Brumelot, E Il'ina, V Alekseenko, G Wehr, G Gerges, B Fitzgerald, M Castellari, I Bratishko, M Dorobantu, I O'Connor, M V Ivan, A Esenokova, M Z Abdul Wahab, S Sylivris, S S S Quek, P Buffet, L Thomas, S Darnes Soler, N Pelicano, B Truong, N Vyshnevaya, M Habab, J Moreira, S Z Lv, D Shukla, P Eavis, E Kryvenkova, S Hansone, S Tabet, M Adda, R Trambitas, L A Fernández Lázaro, M Basara, R Mažutavičius, B Roy, X Dreyfus, T Karaseva, R Tilluckdharry, K Królicka, A Rogowsky, A Rodríguez Fernández, S Junejo, H Ancliff, W K Son, G Bodur, G Pournaras, N Sharapova, J Egido, S Kuanprasert, E Alexanderson, L Vanneste, L Singh, N Bokuchava, D K Jin, E H M Tan, A Bernard, F Baslaib, M A Fazil, M Deissner, F Narro García, R Bonhomme, A Dan, V S Hoang, R Snikytė, O Ratovskaya, T T N Pham, M I Mendonça, F Bates, N Karnaukhova, P Nazeyrollas, L A Elizondo Sifuentes, D Onger, S Yakovova, R Sadłowski, B Doronzo, J Carda, A Taylor, A Albuquerque, V López Mouriño, I Segura Laborda, D O'Donnell, R K Pandey, M Asplanato, M A Paz Bermejo, E Rodríguez, L C Iosipescu, K Fikker, Y Porras Ramos, M Escande, D Binet, J Mantoux, P Barahona Pérez, V Zakirova, A Rocha de Lorenzo, I Konstantinidis, H-H Breuer, B Hockings, A Muthu, Koon-Hou Mak, A Soward, D D Ionescu, P Talbot, F Patriarchi, A Meinel, S Abdel Malak, E Craiu, N Ranjith, B A Lim, R Rosado Soares, G Barauskienė, J Vercammen, N Shelomova, S Govender, S González Romero, K S Ng, D M'Bey, B Al-Khalidi, J Berlingieri, J B Fournier, J Tan, P Mochkina, S Pouwels, G Caridi, D P Phan, P Soskin, D Farcas, C Constance, D Rouse, A Tudose, J M Yu, T T C Nguyen, R Brownlie, J Giordano, A Gigantino, T Yip, A I Noury, R Baroudi, E Pinch, I Landragin, T Cahill, N H Mohd Amin, S Baptista, V Lavicka, P Rodenas, M Jeserich, K F Alhabib, U Teleky, M Ege, D Bierge Valero, D Kozlov, M Vallis, A Rahali, F Maes, E Guiu, P Hutayanon, C Escobar Cervantes, H D Luong, T Salah, J C Ford, C Travill, G Barron, L Rebelo, A S Abdullah, K-H Schermaul, Z Lorenc, F Perreault, O Shamsutdinova, A Fernandes, H Rickli, E Usoltseva, C Cazenave, N Baboshina, P Matthews, N Schön, W Matta, J H Zo, N Pontaga, E Novo García, G R Searles, J A Wang, M S Grocutt, A Kondratovica, P Povolna, J Arnedillo Pardo, J L Prevot, J A Rodríguez Hernández, H Killat, M Hinrichsen, S Santaolalla Rodríguez, F Calvo Iglesias, P Mpompoth, M Claus, K Kunhali, K Panisois, A Lourenço, D Iovescu, I Simkova, C González Juanatey, A Vicentini, C Baranes, J Hilario Jiménez Orozco, M Magherusan, I Orpen, M Horrigan, M Banu, R Weinrich, C Arsenescu Georgescu, R Dubinskaya, Y Kulikova, C Petrillo Pio, N Khishova, R Mika, P Dalampyras, M Maćków, M H Custódio, M A Cobos Gil, Y D Chen, B Bondarenko, V Puel, S Garg, Y Lemiere, J Bruguera Cortada, A Pereira, C Vaticón Herreros, V Ravlyk, G Pons, E Osadchuk, Dayasagar Rao, O Charikova, E Liu, M Baverstock, V Kulygina, J P Dubs, V Climent Payá, M Grobéty, I Krajnc, I Feldmann, A Idoate Gastearena, F Paillard, M Alanbaei, D Sinclair, F Pitella, M Casanovas Pié, R Sheahan, F J Nasser-Sharif, M Goralski, D Kinloch, N Chauhan, M Sandin Rollán, M Didier, N S Pham, W Heddle, N Oleinikova, E Verbrugge, C Amo Fernández, M Kraus, Y K Chan, A M Kushner, K Phillips, V Barriales Alvarez, V Martins, P Talavera Calle, Y Jobic, P Túri, C Greco, G Scalia, J Flores, P Saul, C K Wong, O O'Toole, S Nurgalieva, K Makarenkova, S Hayne, S Kutuzova, N MacCarthy, D Logan, J M Dubois, J Cygler, M Kindel, V Karnot, T Herbots, G Masszi, J de Jesús Rivera Arellano, C Botana Penas, T Vicente Vera, R Karnik, J Morales González, L Lasalle, A S Sahar, R Forrai, A Shekhar Pandey, T Wang, N Maximchuk, A Chung, D Zalewska, O Bashkirtcev, A O'Gara, E Dubinina, H E Harlos, P Meyssonnier, G Dalton, X Tabone, R Capalneanu, I Soosiwala, J Finlayson, H Soleille, T J Hong, I Myhailiv, K Babes, K Modzelewska, Robin Young, K Mayr, J Freire Corzo, J M Bourgeois, S Guerard, F Fernandes, A Loera Pinales, C Schmied, A Minsafina, J Ingham, J Escobedo de la Peña, Y Guo, C Krasucki, R Gendreau, J Bonal, I T Ly, M Jaquet Herter, W Kępa, B Prasad, J L Zamorano Gómez, S Banham, P Ziehn, Nicolas Danchin, C W Goh, M Gonzalvez Ortega, D Dymova, P Bishop, T Dutoya, J E Poulard, P Monnier, O Si, J L Briseño, G Attia, N Khartova, I Gorlova, L Raisova, B Faudon, V Freeman, M Kerbev, U Frank, G Kaliska, A K Ghapar, C Tricot, L Jankowska, V Dormagen, A Pasquet, I Kruglova, P Chemin, J L Díaz Díaz, J H Tao, R Bietzk, G Sceats, K Lai, P Berthezene, Digna R. Velez Edwards, A Buakhamsri, N Bazargani, U Spengler, M Toringhibel, M A Matos, I Skoczylas, V Arrarte Esteban, J Fuertes Beneitez, V Gil, L U P Tran, A Mehta, A Álvarez Sangabriel, P Di Pasquale, K Egstrup, P Choudhury, S Whetstone, T S Chee, M Elkohen, P Martina, J Martínez Rivero, C Arden, J Walczewska, I Benett, R Silvestri, V García Saavedra, J Słaboszewska, A Thomson, S Revienė, A Szpak, V Challenor, F Saporito, P Ruiz Pérez, Vives, H M Li, I Sadykova, D Lawton, T Kuzmina, R Elias, D Troup, P Dehayes, J Vavougios, V Pernice, P Tanielian, R Cabrera Solé, T Pitsch, R Nethononda, P Poinson, A Tavares E Taveira, J Yi-MingCha, J Y Hwang, T Haghfelt, C García Pindado, N Bilous, A Kotsalos, M Bariaud, A Drzewiecka, L Polkina, V Arfaras, P Vymetal, J Rawal, A Aumjaud, H P Wang, L Wu Amen, J Fernandes, F Howie, A Ouguoujil, M H Ngo, J A Bertarini, A Malysheva, G De Geeter, N Aimouch, R Parkin, H Taylor, M Kittipovanonth, A Gupte, S Ramanaidu, L Basto, A Zherebtsova, T Arsentieva, V Männl, Y L Cham, J J Gómez Doblas, D Ennouchi, Iveta Mintale, A Vance, R Jirmar, L Boikova, D T Le, P Srivastava, L Tonet, M Liautard, C Proto, Q H Do, Mª A Pérez Martínez, R Stankevičius, L Semedo, M Anghel, I Nikolaeva, J Janes, H Al-Backer, M C Escourrou Berdou, O Leshchuk, D Reshotko, V P Dang, I Édes, L Schlueter, B Sikorska-Buczkowska, K Hatalova, I Marozsán, S Gessner, J Gmehling, M Kuzmicheva, Z Huang, L Kosareva, D K Kumbla, A Baika, F El-Shaer, T Voronova, J M Chopo Alcubilla, A Veternik, S Mohr, D Garcia, J Y Rhew, C K Yeo, C De Niel, H K N Nguyen, E Orts Soler, J Dubrava, S Natarajan, M S H Khan, U Kossowska, J P Detienne, T T H Nguyen, I Centa, M G Millauer, Jose Lopez-Sendon, J T Counsell, E Galehr, T Schröder, L Frost, P P Singh, C Moya López, R Beyer, L Carpentier, J Carrillo Calvillo, Z M Du, R Steeds, E Horstkotte, P Kindler, P Johnson, M Sander, I Rodríguez Tejero, F Azar Manzur, S Brown, M Odín de los Ríos Ibarra, C K Choor, M A Sadiq, D B Gysan, V B Doan, A Gueusquin, M Andrews, L L Feng, B Martina-Hooi, S R Shetty, Y Dascotte, E T Ch'ng, P Dematteo, A Woodall, S Gabriilidis, Jean Ferrières, S K Oh, J Lindford, S Blignaut, L Macedo, R Carrillo Cardoso, Y C Lai, C Lang, S R Jayasinghe, B Bastian, V Sanfins, J de Jeús Zuñiga, F X Meriaux, G Sepp, S Molotyagina, S García Ortego, T Perger, Y Lukina, J H Wirtz, A Regulska, P Durand, P Loheac, J Sinnadurai, S Avlonitis, J García-Moll Marimón, J Bradley, K Pareathumby, L Latyntseva, D Stergiou, K Ling, S K Hong, N S Chonkar, C Goldie, C C Koo, A Salustri, Y Peneva, I Rodríguez Briones, P Ferreira, L Franskyavichene, G Bragança, C Rodrigues, S H Lee, L Dang, B J Lubelsky, L Weinrich, E Hoffer, J Tricoire, M Marachli, O Smirnova, C Falces Salvador, A Mobeirek, M Fagan, A Serazhim, M M W Yeung, F Petitjean, I Cullen, J Benacka, Yañez Wonenburger, D Gentille Lorente, J Ferreira Dos Santos, F Bosa Ojeda, N Marchionni, L Brottier, P Keelan, D Kerö, L Moretti, R Seabra Gomes, I Jasinkevica, P Purnode, D Relange, H N Luqman, A Petit, I Hamilton-Craig, E Kochurov, P Berry, P Aguar Carrascosa, M Noble, S Yvorra, N Razzaq, J M Walch, L Lenartowska, R Sethi, W Kim, C Killeen, S Kurochkina, N Capuano, P Sampson, K H Mak, T Bouchaya, J Hellermann, M Geneves, F Ramos Ariznabarreta, J L Mougeolle, J Ferreira, T Roy, J de Andrés Novales, J F Monteiro Ferreira, M S Mayer, N Lopez Cabanillas, P Touzet, K H Ng, F Pelier, T K Huynh, J Schindler, T Krechunova, A Gaglione, Z Fras, P Haralambus, R Pradhan, L P Low, G Odent, M Sidor, R Sopia, D Janody, T K Ong, K Adamaszek, G Vives Boniato, T Maxwell, H Charles, D Gough, O Dibon, A A Abdul Rahim, H B Liew, S Tikhonova, I Bläse, J Chambel De Aguiar, E Santas Olmeda, M Rosseel, R Angela, D Savard, C Cernetti, O Huttin, J Calder, O Kilaberiya, A Elkrail, I I Tulevski, A Ilyukhina, E Chalkiadakis, R Antonicelli, H C Gwon, G Bautista López, G Brown, J Kojelienė, R Zeitouni, J Mimoso, N Better, N H Vu, H Abdel Wahab, B Poprawa, F Weber, A Ghicu, K Rybak, G Fouquet, C Pindado Rodríguez, A Salakhova, L Isaeva, M H Fallacher, J Placke, G McCansh, V D Tran, O Gusev, D Enayat, P Khera, E Brice, G Levesque, A Alvarez Auñon, M A Arnau, M A López Aranda, E Andreicheva, I Kruck, R Grigoriu, I Sainz Hidalgo, M Węglarz, A Ajani, I Khudina, T Makhieva, V D Dang, R Testa, E Cisowska-Drozd, F Giacomazzi, R Cierpka, Nicola Greenlaw, P Wong, L Simões, L Tsaryabina, O Gureeva, R Raffelsberger, H Luquez, A Rainbird, D Evéquoz, M A Balice-Pasquinelli, R Massay, K L Joseph, I H Chae, R Herrmann, I Salecker, A Montero Gaspar, P F Fonseca, A Martin, W Czarnecki, R Motomancea, E Dechoux, M Shamsuzzaman, M Leandri, D Marzal Martín, C Navas Navas, C Beaurain, T Gkinis, K Shetty, P A Jeannerat, D S Wong, A Gonzaga, W Kulig, J F Millet, E Jankauskienė, E Anastasiou, A I Ruhani, N Aksyutina, O Kolesova, K Yared, M Panajatovic, Y L Zhou, S Thurston, T Alekseeva, S Preston, N Mai, M Kuzyakina, D Rechtman, T Boonyasirinant, J Nobre Dos santos, A Ahuad Guerrero, M Al-Shamiri, M Feldner-Busztin, S Godart, S Liandrat, A Narayan, L Burlakova, M J García Martínez, C Militaru, J Chávez Paez, H B Matheson, D Meddah, P Brindle, N Petrova, A Nicolino, D Spensieri, A Giuca, E Molina Laborda, J Moreno Arribas, V Martinho, T Mularek-Kubzdela, S K Chua, G A Dan, N T H Tu, V T Nguyen, M Alcocer Gamba, J Costa, H Milligan, R Badr-Eslam, E Variava, A Merkhi, C Mays, R De Castro Aritmendiz, A K Mohamed Yusof, A Hamer, R McNeilly, S Dedkova, D Rousson, K Chamou, A Mahr, D C Dan, R Till, T L Yang, M Vida Gutiérrez, D Piyayotai, É Bajcsi, D Zaronskienė, I Alexopoulos, Y Huo, H S Zeng, P Rowe, S Fleming, D B Vu, Á Dongó, C Hand, J C S Leong, M Claeys, S Hood, J Bozkova, G Vieyra, G Unger, A Liqui-Lung, D Cremer Luengo, M Castillo Orive, S Muth, M Joseph, P L Torres Díaz, C Zakopoulos, D Cross, F Trujillo Berraquero, F Sattar, H A Boyrazian, T B Le, M Mantcheva, M Constantinescu, P Gosse, U Keil, G F Vaz, M Bdeir, T S Pham, M J García González, J K Ryu, D W Jeon, Zs Malkócs, J Á Perea Egido, R Izquierdo González, V Probst, E Wellenkamp, C Boureux, M Czarnecka, C Vaughan, H Falconer, H Brunner, G Peña Pérez, E Nelböck-Huber, E Blanc, F Thomas-Richard, A L R Ng, M Provvidenza, R Gascueña Rubia, J Freitas, A Dabboura, B Mörz-Proszowski, A Utech, C Alves, C M David, J A Lastra Galán, L Oliveira, T A Nguyen, I Ghaly, A Hofmeister, I Gorodilova, P Szałkowski, M S Hiremath, G Golovina, C Daly, M Tardy, S Kostomarova, J-P Salembier, P Zagožen, D Wang, M Vogel, J Borbola, I Chlewicka, K-H Schmitz, C Pappas, J Victory, M Garandeau, P Wiggers, C Piñero Ramírez, L Tkhorzhevskaya, E Suglobova, V Samakhovets, P Surmont, H A Ramírez Reyes, M Winter, F Prunier, B Cavert, B Salaun, J M Roca Catalán, A Beinhauer, Ian Ford, K Elsby, V Knyazeva, C Tamburino, V Khoury, A Felice Castro Issa, B Marchenko, K König, A Kennedy, J M Alegret Colomer, T Gillet, Clarify Investigators, B Maheu, A Troncoso Gil, N Haldane, B Koujan, T Mouhat, A Waldman, J Robert, J Campbell, A Kokis, M Micheals, P Gori, P Ramoutar, M Al Zaibag, V Ryzhkova, M Kazakovtseva, C Bernardeau, B Ferreiro Rodríguez, Y Voloshko, S Szabo, I Jarvis, Y N Ke, J Donetti, A Serrano-Garcia, R Ketelers, S Grigoryan, V Kulik, P Zündorf, L Kleemann, J McPherson, M Luaces Méndez, F Mouquet, L G Xiong, T H Tran, P Costello, A Potter, M Cinteza, F Colivicchi, E Nowicka, O Greiner, G Reddy, M Martins Oliveira, F Fernandes De Sousa, P Nocon, R Sewell, I Nikodemska, R Tadeu Munhoz, T Gilbert, I Laizane, M Maroun, B Demianiuk, A Bolidai, R Kacorzyk, R Fernández Mouzo, K Karastanev, J Blanco Castiñeiras, P Messali, R Schwarz, M Vardhani, O Gouli, C Thelemann, A Forclaz, G Khaznadar, G Eisele, P Sosner, M L Bourachot, N Pontikakis, S Heinemann-Meerz, E Zatsarina, E Smrckova, P Calmettes, D H Kang, M L Santos Iglesias, S M Marinescu, A Heap, Melnikova, N F Strathmore, S Tolpygina, M Yang, M Naisseh, E George, J Banach, E Delcoulx, E Teijeira Fernández, J Poles, P Saunders, S Haddad, T Q Luu, A Dhesi, O Prikolota, M Baar, P Lafontaine, C O'Dong, I Petropoulos, B-M Altevogt, D Warden, T De Backer, G Miñana Escrivá, T L Mai, U Schlesinger-Irsch, M M Gomaa, E Moksyuta, M Drexler, P Monteiro, P Grooterhorst, J Moolman, P McAlavey, J O'Shea, L P Quinn, F Crespo, K Srinivasa Reddy, T Shokina, Ellen M. Schmidt, M H Jeong, K Denef, A Pleskof, I Takács, Y Tikhonov, O Ushakov, L Stevens, J Ezcurdia Sasieta, L Nkombua, O Henne Otero, J Y Fraboulet, D S Kim, G Hoh, A Tamm, M Sardon, G Chatzioakim, M A Ulecia Martínez, S Reymond, M Myint, G Proença, R Massabie, E Foster, H Dougall, Anjan Kumar Roy, C Franco Aranda, M Getman, E Filippova, C Aguiar, X D Pu, N Voronina, L L Chen, M Szulc, L Bayakhchan, M J Pinto Vaz, C Niederberger, N Vites, I Sen, Paul R. Kalra, J A Castillo Moreno, W K Ng, C Brunschwig, D Morgan, A Concepción Clemente, N Yakimova, J M Guy, A H Jaafar, J Badarienė, N Taylor, L Compson, R Amor, A Maximovitch, J L Bardají Mayor, E Marín Araez, N H Chau, N Srtumilenko, K Kelly, A Papathanasioy, S Erofeev, B Mamez, A Ribeiro, M Micko, N Alvarenga Recalde, K Atueva, Z Sebõk, P Kycina, A K Gupta, A Laucevičius, R Ahuja, A Prokop, P Stadler, S De Ridder, L Zhang, F B Ramadan, L Kapustina, V Fedoskin, A Bateman, C A Nacht, R Musetescu, M Aparici Feal, A Büttl, S Ross, M Rau, P Federico Zaragoza, G Brisson, M Zagreanu, T T H Pham, F Dominé, N Davydova, N Petrochenko, N Paul, P H Truong, S Frickel, W Bryl, G Brouillette, A Stumpp, M Barrera Bustillos, C Ziccarelli, O Zalyzniak, M eatherhead, N Watkins, G Riccioni, l Kudryavtsev, R Carvalho, J P S Sawhney, V González Toda, P Matos Dias, M Giorgadze, I Rodriguez Marrero, W Gritsch, K Lee, G W Kellam, I Parker, V Ecina, Mª I Soto Ruiz, C Delhomme, T Ivaschenko, Y W Cheah, I Grudtsina, R Chehayeb, T Dookie, O Krasnoslobodskaya, P Jarmużek, F Van den Branden, A M F Vandeplas, A Rocha De Almeida, M Espiga De Macedo, E Łotocka, K Nagy, R Paliulionienė, J L Leyva Pons, N Fedorova, Y Yanina, O Stasuk, Z Vlasuk, P Lim, P Egloff, T Berezhna, A Faria, J Cerda Rojas, E Moser, H G Jin, S J Oh, G Arquero García, K H Karner, I Leontaridis, A Banikova, J Fridrich, H Lesseliers, I Pokrovskaya, P Astridge, H Abdul Manap, R Daniel, C A Almeida Fernández, A Nowowiejska-Wiewióra, B Carvalho De Moura, M Malden, H Rosenstein, S Dixon, G Balogh, M Adam-Blanpain, A Sandalian, H Gervas Pavón, G A Antoniadis, N Naberezhnova, A Amlaiky, P Terrosu, K K H Lau, B Chartier, X Su, O Kovyrshyna, G Beale, P Primot, M H Chen, S S Ramesh, R Chyrek, E Gómez Álvarez, J Rodríguez Collado, G Sibilio, R Jeremiasz, R Colin, C Lalla, G M Fullerton, M P Samal, H Thümmel, R P Patel, J Takhar, H M Kwon, T A Cieza Lara, F Magliari, J Morrell, M Rayo Gutiérrez, T L Orenstein-Lyall, H Choi, S Kulinich, A Aftab, A Wallace, B B Abdul Kareem, S Kwok, A Królak, A Grover, Laurent Fauchier, Mª J Pinilla Lozano, G Sengupta, D Paris, M Al Dhanki, J Milewski, F Petersen Aranguren, H Brufau Redondo, H Mayr, A Arias Mendoza, M Ducoudre, A Correia, J S Awtar Singh, P Aylward, E Brscic, J Du Plooy, J L Arenas León, G Silva Alves, L Sreenivasa Murthy, P Dendale, F La Varra, S Minkin, T Eggeling, A Jamiel, G Lebischak, E Andreev, T V A Tuong, V Chaithiraphan, O Duprez, S Higgins, F Chometon, Y Cottin, A Bonny, C Guyetand, J Matos, F Henpin Yue Cesena, L Polyaeva, M Drijfhout, J Toplak, G E Vertes, N F Wang, J Doucet, A K Trivedi, P Turek, G Chouinard, A Al Lawati, W Filip, F Kovar, T J Cha, A Belanger, H L Cong, J F Robert, D López Gómez, J L Sanz Rodríguez, H Simper, P Shetty, A Chukwu, E Bukanina, C Amoros Galito, H MacCowan, T T T Tran, A Singal, K C Vu, O Ismail, A Ardiaca Capell, P Bousquet, F Goss, Z Galeeva, Maxime Guenoun, B Rijavec, Z Lazerevic, A McCracken, A C Motoc, Y Sharapova, S Wright, A J Paule Sánchez, L Mainar Latorre, I Sirazov, X L Yang, S E Paget, G Berkenboom, J Markenvard, I Surovtseva, S K George, Matthias Simon, M L Fuantos Delgado, C Christoforidis, M Lagares Carballo, P Alvarez García, J Könemann, L Crawford, I Gonos, D Saulnier, E Szabó, L Ardouin, J Bhayat, F J Abardía Oliva, X Bernard, O Sirbu, P Boutsikos, N Khmelevskikh, E Tavlueva, P LeBouthillier, I Bourazanis, A Sequeira, M López Martínez, C P Paulus, R K M Bhaskaran, F Pellerin, B Brown, B Saleh, A Lacchè, R Sola Casado, E Kaźmierczak, M Weingrod, and G Vijayaraghavan
- Subjects
medicine.medical_specialty ,Cardiac & Cardiovascular Systems ,Epidemiology ,LONG-TERM ,medicine.medical_treatment ,Chronic coronary syndromes ,Coronary Artery Disease ,Revascularization ,Ventricular Function, Left ,GLUCOSE ,MELLITUS ,Risk Factors ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,Ethnicity ,Prevalence ,medicine ,Humans ,ARTERY-DISEASE ,Myocardial infarction ,Stroke ,RISK ,OUTCOMES ,Ejection fraction ,Science & Technology ,business.industry ,Proportional hazards model ,CLARIFY Investigators ,Hazard ratio ,Diabetes ,Stroke Volume ,Geographical disparities ,Syndrome ,medicine.disease ,MIDDLE-EAST ,EUROPEAN-SOCIETY ,Treatment Outcome ,MYOCARDIAL-INFARCTION ,Heart failure ,CLARIFY registry ,Cardiovascular System & Cardiology ,HEART-FAILURE ,Cardiology and Cardiovascular Medicine ,business ,Life Sciences & Biomedicine - Abstract
BackgroundIn contrast with the setting of acute myocardial infarction, there are limited data regarding the impact of diabetes mellitus on clinical outcomes in contemporary cohorts of patients with chronic coronary syndromes. We aimed to investigate the prevalence and prognostic impact of diabetes according to geographical regions and ethnicity.Methods and resultsCLARIFY is an observational registry of patients with chronic coronary syndromes, enrolled across 45 countries in Europe, Asia, America, Middle East, Australia, and Africa in 2009–2010, and followed up yearly for 5 years. Chronic coronary syndromes were defined by ≥1 of the following criteria: prior myocardial infarction, evidence of coronary stenosis >50%, proven symptomatic myocardial ischaemia, or prior revascularization procedure.Among 32 694 patients, 9502 (29%) had diabetes, with a regional prevalence ranging from below 20% in Northern Europe to ∼60% in the Gulf countries. In a multivariable-adjusted Cox proportional hazards model, diabetes was associated with increased risks for the primary outcome (cardiovascular death, myocardial infarction, or stroke) with an adjusted hazard ratio of 1.28 (95% confidence interval 1.18, 1.39) and for all secondary outcomes (all-cause and cardiovascular mortality, myocardial infarction, stroke, heart failure, and coronary revascularization). Differences on outcomes according to geography and ethnicity were modest.ConclusionIn patients with chronic coronary syndromes, diabetes is independently associated with mortality and cardiovascular events, including heart failure, which is not accounted by demographics, prior medical history, left ventricular ejection fraction, or use of secondary prevention medication. This is observed across multiple geographic regions and ethnicities, despite marked disparities in the prevalence of diabetes.ClinicalTrials identifierISRCTN43070564
- Published
- 2021
4. Lipid levels, atrial fibrillation and the impact of age:Results from the LIPIDOGRAM2015 study
- Author
-
Stephanie L. Harrison, Deirdre A. Lane, Maciej Banach, Mirosław Mastej, Sławomir Kasperczyk, Jacek J. Jóźwiak, Gregory Y.H. Lip, B. Al-Shaer, W. Andrusewicz, M. Andrzejczuk-Rosa, E. Anusz-Gaszewska, A. Bagińska, P. Balawajder, G. Bańka, E. Barańska-Skubisz, B. Barbara Przyczyna, S. Bartkowiak, J. Bartodziej, M. Bartosiewicz, M. Basałyga, A. Batyra, A. Bąk, M. Bednarz, K. Bejnar, W. Bernacki, M. Betiuk-Kwiatkowska, S. Biegaj, M. Bień, W. Bilski, M. Biłogan, G. Biruta-Pawłowska, A. Biskup, B. Błaszczyk, H. Błaszczyk, T. Błońska-Jankowska, B. Bogacka-Gancarczyk, M. Bojanowska, E. Bonda, J. Borowik-Skwarek, J. Borowska, J. Bruckner, J. Brzostek, M. Brzuchacz, M. Budzyńska, I. Bulzacka-Fugiel, J. Bulzak, K. Bunikowski, A. Cebulska, T. Celka, E. Cempel-Nowak, W. Chechliński, A. Chludzińska, D. Chmiel, M. Chmielewska, M. Cichy, A. Ciemięga, A. Ciepluch, I. Cieszyńska, B. Czajka, B. Czapla, M. Czerner, B. Czerwińska, W. Czuryszkiewicz, E. Daleka, Z. Dawid, M. Dąbrowska, R. Dąbrowska, D. Dąbrowski, M. Dąbrowski, K. Demczyszyn, A. Dębowska-Serwińska, J. Dmochowski, J. Dobrzecka-Kiwior, E. Dolanowska, H. Dolanowski, P. Dołek, M. Domagała, H. Domański, A. Doszel, D. Duda, M. Dudkowska, B. Dudziuk, P. Dybciak, M. Dymanowski, L. Dziadzio-Bolek, M. Eicke, H. El-Hassan, A. Eremus, M. Fąferek-Muller, E. Figura-Roguska, I. Fijałkowska-Kaczmarek, M. Flis, T. Florczak, M. Florczuk, E. Foryszewska-Witan, W. Frydrych, A. Fugiel, E. Futyma, A. Gaca-Jaroszewicz, I. Gajdamowicz, K. Ganczarski, A. Gatnar, M. Gers, A. Głowacki, K. Głód, J. Godula, J. Gołąb, M. Gołębiewski, E. Goszczyńska, K. Gościcka, A. Górna-Hajduga, E. Górny, T. Grabowska, R. Grabowski, A. Graczyk-Duda, A. Gromow, A. Grudewicz, J. Gruszecka, A. Gruszka, J. Gryboś, J. Grzebyk, A. Grzechowiak, D. Grzesiak, T. Grześkowiak, A. Guźla, G. Hachuła, B. Hawel, H. Hiltawska, E. Honkowicz, J. Ignatowicz, K. Imielski, A. Iwaniura, A. Jagieła-Szymala, M. Jalć-Sowała, A. Janczylik, E. Janisz, M. Janiszek, K. Jankiewicz-Ziobro, K. Januszewska, A. Jaremek, A. Jaros-Urbaniak, J. Jarosz, P. Jarosz, W. Jasiński, M. Jezierska-Wasilewska, T. Jędraszewski, A. Jędrzejowska, R. Józefowicz, J.J. Jóźwiak, K. Juźwin, E. Kacprzak, J. Kaczmarek-Szewczyk, M. Kaczmarzyk, R. Kandziora, C. Kaniewski, L. Karolak-Brandt, S. Kasperczyk, E. Kasperek-Dyląg, I. Kedziora, A. Kępa, J. Kiciński, J. Kielak-Al-Hosam, Ł. Kiełczawa, P. Kilimowicz, K. Kitliński, T. Kiwka, U. Klein, L. Klichowicz, A. Klimowicz, B. Klonowski, B. Kmolek, E. Kobyłko-Klepacka, A. Kocoń, A. Kolenda, E. Kollek, M. Kopeć, B. Koper-Kozikowska, J. Koralewska, M. Korczyńska, M.T. Korzeniewski, A. Kosk, K. Kotarski, E. Kowalczyk, M. Kowalczyk, I. Kowalik, B. Kozak-Błażkiewicz, M. Kozik, D. Kozłowska, E. Kozłowska, M. Kozłowska, T. Kozubski, K. Kózka, L. Kraśnik, T. Krężel, B. Krochmal, B. Król, G. Król, J. Król, T. Królikowska, H. Kruszewska, B. Krygier-Potrykus, W. Krystek, J. Krzysztoń, T. Kubicki, A. Kuczmierczyk-El-Hassan, W. Kuczyńska-Witek, D. Kujda, A. Kurowski, I. Kurzelewska-Solarz, M. Kwaczyńska, M. Kwaśniak, P. Kwaśniak, T. Kwietniewska, A. Łebek-Ordon, A. Lebiedowicz, L. Lejkowska-Olszewska, M. Lentas, A. Lesiewicz-Ksycińska, M. Limanowski, S. Łoniewski, J.A. Łopata, B. Łubianka, I. Łukasiuk, M. Łużna, M. Łysiak, B. Łysik, Z. Machowski, J. Maciaczyk-Kubiak, G. Mackiewicz-Zabochnicka, Z. Magner-Krężel, S. Majda, P. Malinowski, J. Mantyka, E. Marchlik, G. Martyna-Ordyniec, J. Marzec, M. Marzec, R. Matejko-Wałkiewicz, M. Mazur, M. Michalczak, A. Michalska-Żyłka, M. Michniewicz, D. Mika-Staniszewska, E. Mikiciuk, T. Mikołajczak, J. Milewski, E. Miller, B. Misiaszek, M. Mizik-Łukowska, E. Młyńczyk-Pokutycka, M. Mocek, M. Moczała, M. Morawska-Hermanowicz, P. Moryc, A. Moskal, S. Moskal, A. Moździerz, P. Moździerz, M. Mrozińska, K. Mrozowicz, G. Mróz, T. Munia, A. Mura, M. Muras-Skudlarska, E.Z. Murawska, Ł. Murawski, R. Murawski, R. Musielak, K. Nadaj, W. Nagarnowicz, R. Napierała, M. Niedźwiecka, A. Niemirski, J. Nikiel, M. Nosal, W. Nowacki, J. Nowak, M. Nyrka, A. Obst, J. Ochowicz, E. Ogonowska, M. Oleszczyk, A. Ołdakowski, I. Ołowniuk-Stefaniak, J. Ordowska-Rejman, M. Orliński, B. Osińska, A. Ostańska-Burian, A. Paciorkowska, U. Paczkowska, L. Paluch, L. Pałka, J. Paszko-Wojtkowska, A. Paszkowska, E. Pawlak-Ganczarska, W. Pawlik, I. Pawłowska, M. Paździora, G. Permiakow, A. Petlic-Marendziak, T. Piasecka, E. Piaścińska, A. Piktel, A. Pilarska-Igielska, A. Piotrkowska, K. Piwowar-Klag, M. Planer, J. Plewa, P. Płatkiewicz, B. Płonczyńska, A. Podgórska, M. Polewska, B. Porębska, P. Porwoł, I. Potakowska, A. Prokop, J. Przybylski, M. Przybyła, H. Psiuk, K. Ptak, G. Puzoń, N. Rabiza, S. Rachwalik, E. Raczyńska, M. Raniszewska, A. Romanek-Kozik, A. Rosa, K. Rosa, A. Rozewicz, J. Rudzka-Kałwak, J. Rusak, D. Rutkowska, M. Rybacki, D. Rybińska, A. Rycyk-Sadowska, L. Rynda, B. Rynkiewicz, B. Sadowska-Krawczyk, M. Sadowska-Zarzycka, B. Sarnecka, E. Sawalach-Tomanik, B. Sidor-Drozd, M. Siemieniak-Dębska, A. Sieroń, B. Siewniak-Zalewska, A. Sikora, B. Sitarska-Pawlina, J. Skorupski, I. Skrzypińska-Mansfeld, J. Skubisz, R. Skwarek, M. Słodyczka, M. Smentek, K. Smolińska, B. Solarz, W. Sosnowska, B. Sroka, H. Stachura, D. Stangreciak, M. Staniak, Z. Stańczyk, D. Stańszczak-Ozga, E. Startek, M. Stefańczyk, R. Stelmach, E. Sternadel-Rączka, M. Sternik, J. Stępień, J. Stocka, M. Stokowska-Wojda, M. Studler-Karpińska, W. Suchorukow, W. Sufryd, B. Supłacz, J. Sygacz, Ł. Szczepański, J. Szkandera, J. Szłapa-Zellner, D. Szydlarska, T. Śliwa, J. Śliwka, Ł. Śmiejkowski, A. Targońska, E. Tesarska, M. Tobiasz, J. Tomaka, K. Tomalska-Bywalec, E. Tomiak, S. Topczewski, A. Trawińska, L. Trela-Mucha, D. Trojanowski, M. Trzaskowska, B. Trzcińska-Larska, A. Trznadel-Mozul, K. Ulanicka-Liwoch, M. Urbanowicz, A. Uthke-Kluzek, J. Waczyński, J. Walczak, L. Warsz, M. Wasyńczuk, U. Wąchała-Jędras, D. Wąsowicz, J. Wczysła, F. Wenda, E. Werner-Kubicka, E. Weryszko, B. Węgrzynowska, M. Wiaksa, M. Wiankowski, A. Wicherek, R. Wieczorek, R. Wiencek, G. Wienzek-Tatara, B. Wierzbicka, M. Wierzbicki, B. Wilczyńska, D. Wilmańska, P. Winiarski, A. Wiszniewska-Pabiszczak, M.B. Witkowska, J. Witzling, A. Wlaź, I. Wojtkowiak, J. Woydyłło, K. Woźniak, A. Wójtowicz, J. Wrona, M. Wrońska, H. Wujkowska, J. Wyrąbek, O. Wysokiński, R. Zakrzewski, J. Zaleska-Zatkalik, J. Zaleski, M. Zalewska- Dybciak, E. Zalewska, B. Zalewska-Uchimiak, J. Zawadzka-Krajewska, J. Zawadzki, A. Zieliński, E. Zubrycka, I. Żybort, and M. Żymełka
- Subjects
0301 basic medicine ,Multivariate statistics ,medicine.medical_specialty ,Inverse Association ,Epidemiology ,030204 cardiovascular system & hematology ,03 medical and health sciences ,symbols.namesake ,0302 clinical medicine ,Age ,Age groups ,Risk Factors ,Total cholesterol ,Internal medicine ,Atrial Fibrillation ,medicine ,Prevalence ,Humans ,Poisson regression ,Triglycerides ,Lipoprotein cholesterol ,business.industry ,Cholesterol, HDL ,Atrial fibrillation ,Cholesterol, LDL ,medicine.disease ,Lipids ,030104 developmental biology ,Cholesterol ,Quartile ,symbols ,Cardiology ,lipids (amino acids, peptides, and proteins) ,Poland ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background and aims: An inverse relationship between lipid levels and atrial fibrillation (AF) has been suggested, but whether the association is upheld for all age groups remains unclear. The aim of the study was to examine associations between lipid levels and AF by age groups in a nationwide study in Poland. Methods: Multivariate Poisson regression models were used to estimate prevalence ratios (PRs) for AF by lipid levels. Low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), total cholesterol (TC), non-HDL-C and LDL-C/HDL-C ratios were grouped into quartiles. Results: Of the 13,724 participants, 5.2% (n = 708) had AF. People with AF were older with more comorbidities, but lower lipid levels (all p < 0.05). The prevalence of AF was inversely associated with LDL-C (Adjusted PR (95% Confidence Interval) highest versus lowest quartile: 0.60 (0.48, 0.75)), TC (0.61 (0.49, 0.75)) and non-HDL-C (0.63 (0.51, 0.78)). The prevalence of AF was inversely associated with HDL-C (0.58 (0.46, 0.74)), but this was not statistically significant for people aged 75 years and older. For the LDL-C/HDL-C ratio, the prevalence of AF was only inversely associated with higher levels for people aged 75 years and older (0.75 (0.61, 0.94)). There was no statistically significant difference in prevalence of AF by TG levels. Conclusions: The results suggest an inverse relationship between lipid levels and AF. The inverse association between higher HDL-C and AF was only significant for people aged
- Published
- 2020
5. Antimicrobial Potential of Caffeic Acid against Staphylococcus aureus Clinical Strains
- Author
-
Tomasz J. Wąsik, Konrad Korzeniowski, Maria Miklasińska-Majdanik, Małgorzata Kępa, Danuta Idzik, Robert D. Wojtyczka, and Joanna Smoleń-Dzirba
- Subjects
0301 basic medicine ,Methicillin-Resistant Staphylococcus aureus ,Staphylococcus aureus ,Article Subject ,medicine.drug_class ,Antibiotics ,ANTIBACTERIAL ACTIVITY ,INHIBITION ,lcsh:Medicine ,Microbial Sensitivity Tests ,Research & Experimental Medicine ,SUSCEPTIBILITY ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,Microbiology ,03 medical and health sciences ,chemistry.chemical_compound ,Minimum inhibitory concentration ,Caffeic Acids ,Anti-Infective Agents ,ANTIOXIDANT ,medicine ,Caffeic acid ,Humans ,COMBINATION ,Science & Technology ,General Immunology and Microbiology ,IDENTIFICATION ,lcsh:R ,Clindamycin ,Drug Synergism ,General Medicine ,IN-VITRO ,Antimicrobial ,PHENOLIC-COMPOUNDS ,Methicillin-resistant Staphylococcus aureus ,Anti-Bacterial Agents ,030104 developmental biology ,chemistry ,Biotechnology & Applied Microbiology ,Medicine, Research & Experimental ,ANTIBIOTIC-ACTIVITY ,Vancomycin ,Life Sciences & Biomedicine ,SKIN ,medicine.drug ,Research Article - Abstract
Phenolic compounds constitute one of the most promising and ubiquitous groups with many biological activities. Synergistic interactions between natural phenolic compounds and antibiotics could offer a desired alternative approach to the therapies against multidrug-resistant bacteria. The objective of the presented study was to assess the antibacterial potential of caffeic acid (CA) alone and in antibiotic-phytochemical combination againstStaphylococcus aureusreference and clinical strains isolated from infected wounds. The caffeic acid tested in the presented study showed diverse effects onS. aureusstrains with the minimum inhibitory concentration (MIC) varied from 256μg/mL to 1024μg/mL. The supplementation of Mueller-Hinton agar (MHA) with 1/4 MIC of CA resulted in augmented antibacterial effect of erythromycin, clindamycin, and cefoxitin and to the lesser extent of vancomycin. The observed antimicrobial action of CA seemed to be rather strain than antibiotic dependent. Our data support the notion that CA alone exerts antibacterial activity againstS. aureusclinical strains and has capacity to potentiate antimicrobial effect in combination with antibiotics. The synergy between CA and antibiotics demonstrates its potential as a novel antibacterial tool which could improve the treatment of intractable infections caused by multidrug-resistant strains.
- Published
- 2018
- Full Text
- View/download PDF
6. Antibacterial Activity of Protocatechuic Acid Ethyl Ester on Staphylococcus aureus Clinical Strains Alone and in Combination with Antistaphylococcal Drugs
- Author
-
Maria Miklasińska, Anna Zdebik, Danuta Idzik, Tomasz J. Wąsik, Kamila Orlewska, Robert D. Wojtyczka, and Małgorzata Kępa
- Subjects
Staphylococcus aureus ,medicine.drug_class ,Pharmaceutical Science ,Biology ,medicine.disease_cause ,Article ,Analytical Chemistry ,Microbiology ,lcsh:QD241-441 ,Minimum inhibitory concentration ,antibacterial activity ,synergistic effect ,lcsh:Organic chemistry ,Drug Discovery ,Drug Resistance, Bacterial ,medicine ,Hydroxybenzoates ,Humans ,Cefoxitin ,Physical and Theoretical Chemistry ,protocatechuic acid ethyl ester ,Lincosamides ,Organic Chemistry ,Clindamycin ,biochemical phenomena, metabolism, and nutrition ,Antimicrobial ,Anti-Bacterial Agents ,Chemistry (miscellaneous) ,Molecular Medicine ,Vancomycin ,Antibacterial activity ,medicine.drug - Abstract
The aim of the presented study was to examine in vitro the antibacterial activity of protocatechuic acid ethyl ester (ethyl 3,4-dihydroxybenzoate, EDHB) against Staphylococcus aureus clinical isolates alone and in the combination with four selected antibiotics. The EDHB antimicrobial activity was tested against twenty S. aureus strains isolated from the clinical samples, and three reference strains. The phenotypes and genotypes of resistance to methicillin for the tested strains were defined as well as the phenotypic resistance to macrolides, lincosamides and streptogramin B (MLSB). EDHB displayed diverse activity against examined S. aureus strains with the minimal inhibitory concentration (MIC) within the range from 64 to 1024 µg/mL. Addition of ¼ MIC of EDHB into the Mueller-Hinton Agar (MHA) resulted in augmented antibacterial effect in the presence of clindamycin. In the case of cefoxitin no synergistic effect with EDHB was noted. For erythromycin and vancomycin the decrease of mean MICs in the presence of EDHB was observed but did not reach statistical significance. The results of the present study showed that in vitro EDHB possesses antibacterial activity against S. aureus clinical strains and triggers a synergistic antimicrobial effect with clindamycin and to the lesser extent with erythromycin and vancomycin.
- Published
- 2015
7. Cerebrospinal fluid ferritin concentration in patients with purulent, bacterial meningitis – own observations
- Author
-
Lucjan, Kępa, Barbara, Oczko-Grzesik, Wojciech, Stolarz, and Anna, Boroń-Kaczmarska
- Subjects
Adult ,Male ,Interleukin-6 ,Meningoencephalitis ,Ferritins ,Humans ,Female ,Ciliary Neurotrophic Factor ,Prognosis ,Severity of Illness Index ,Biomarkers ,Meningitis, Bacterial - Abstract
The aim of the study was to evaluate the usefulness of cerebrospinal fluid (CSF) ferritin concentration assessment in adults with purulent, bacterial meningoencephalitis.The investigation was performed in 18 subjects hospitalized at the Clinical Ward of Infectious Diseases, Medical University of Silesia in Bytom from 2008 through 2012, for purulent, bacterial meningoencephalitis. The patients were divided into two groups, according to severity of their clinical condition: Group I – very severe course of the disease, group II – moderate and mild course of the disease. In all the individuals, CSF interleukin-6 concentration was evaluated during the first 24 hours of hospitalization.Mean CSF ferritin concentration in patients in very severe clinical condition (group I) was 314.71 ng/mL as compared to 162.13 ng/mL in subjects of group II with moderate and mild course of the disease. The difference between CSF mean concentration of this cytokine was statistically significant (p0.01). Correlations between CSF ferritin and CSF protein and lactate were determined. The control assays performed in 6 patients from group I revealed only slightly decrease of CSF ferritin level in the fatal course of the disease. In survivals with recovery CSF concentration of this protein was decreased markedly as compared to the initial level.The obtained results indicate the usefulness of CSF ferritin concentration assessment in estimation of intensity of inflammation in the subarachnoid space, and indirectly, of severity of the patient’s clinical condition. The level of this protein concentration also seems to be helpful as a prognostic marker in purulent, bacterial meningoencephalitis.
- Published
- 2017
8. Acute liver failure during treatment of interferon alpha 2a chronic hepatitis B and coinfection of parvovirus B19
- Author
-
Barbara, Sobala-Szczygieł, Anna, Boroń-Kaczmarska, Lucjan, Kępa, Barbara, Oczko-Grzesik, Damian, Piotrowski, and Wojciech, Stolarz
- Subjects
Adult ,Parvoviridae Infections ,Hepatitis B, Chronic ,Coinfection ,Parvovirus B19, Human ,Humans ,Interferon-alpha ,Female ,Liver Failure, Acute ,Antiviral Agents ,Recombinant Proteins ,Polyethylene Glycols - Abstract
Parvovirus B19 infection is associated with a broad spectrum of clinical manifestations among which some are well known but others remain controversial. The role of this infection as a cause of acute hepatitis or exacerbation of chronic liver disease requires discussion regarding its significance in a strategy of prevention and treatment of patients with chronic hepatitis. Clinical importance of this infection in patients with chronic hepatitis B treated with pegylated interferon alpha 2a is still unclear but exactly in this population significant complications during treatment may arise. Parvovirus B19 infection is not rare among persons with chronic hepatitis B, therefore searching for co-infection should be placed in standard diagnostic procedures especially in case of exacerbation of chronic hepatitis, pancytopaenia or anaemia of unknown origin. Pegylated interferon alpha 2a still remains a gold standard of therapy of patients with chronic hepatitis B according to European (EASL) and Polish guidelines. We present a case of 35 years old woman treated with pegylated interferon alpha 2a who developed acute liver failure in 23rd week of chronic hepatitis B therapy. An exacerbation of hepatitis with encephalopathy and pancytopaenia have been observed. Parvovirus B19 and HBV co-infection does not increase the frequency of liver function abnormalities in patients with chronic hepatitis B. Further investigations should be done to describe the natural course of co-infection with parvovirus B19 and HBV and to establish possible association between parvovirus B19 infection and chronic hepatitis B and also the influence of interferon alpha 2a on the infections course.
- Published
- 2016
9. [Ocular toxocariasis in a boy with idiopathic nephrotic syndrome - a case report]
- Author
-
Agnieszka, Antonowicz, Piotr, Skrzypczyk, Beata, Kępa, and Małgorzata, Pańczyk-Tomaszewska
- Subjects
Male ,Nephrotic Syndrome ,Toxocariasis ,Eye Diseases ,Child, Preschool ,Animals ,Humans ,Prednisone ,Albendazole ,Child - Abstract
Toxocariasis is a common zoonosis caused by infection with Toxocara canis or cati larvae. Ocular toxocariasis is one of the forms of infestation found in 1/1,000 - 1/10,000 children. Children with idiopathic nephrotic syndrome (INS) are at high risk of infections, also parasitic infestations, which can, in turn, cause relapses of the disease.We present a case of a 6-year-old boy with steroiddependent nephrotic syndrome. The disease started at age of 2, the boy had 9 relapses of INS, and was treated with oral prednisone, levamisole, and cyclophosphamide. During hospitalization with Xth relapse of INS, he was screened for causes of recurrences and IgG antibodies against Toxocara were found. Fundoscopy revealed white, slightly elevated, and discoloured inflammatory lesions in right retina without inflammation in the vitreous. Ocular toxocariasis was diagnosed. The boy was treated for 7 days with albendazole in the dose of 15 mg/kg/24 h with simultaneous increase of the dose of prednisone to 1mg/kg/24 h. In control fundoscopic examinations there was no progression of ocular lesions.In children on immunosuppressive treatment with possible exposure to animals or raw meet it is advisable to take serological tests for Toxocara infestation also in the absence of clinical symptoms of parasitic infection.
- Published
- 2016
10. [Impact of low level laser therapy on skin blood flow]
- Author
-
Jacek, Podogrodzki, Michał, Lebiedowski, Mieczysław, Szalecki, Izabela, Kępa, Małgorzata, Syczewska, and Sergiusz, Jóźwiak
- Subjects
Male ,Meningomyelocele ,Adolescent ,Child, Preschool ,Hemodynamics ,Humans ,Female ,Low-Level Light Therapy ,Child ,Skin Diseases ,Blood Flow Velocity - Abstract
The aim of this study was to objectively assess the impact of low level laser therapy on skin blood flow, in terms of two of its components - the flow and trophic and therapeutic effect.Nineteen children aged 3-15 years have been included in the study (seven boys and twelve girls) with a diagnosis of meningomyelocele in the lumbosacral area. In nine of them (47.3%) bedsores were found in the area of paresis location. Studies of skin blood flow were performed using xenon 133 clearance in the Department of Nuclear Medicine of the Children's Memorial Health Institute. Xenon 133 radioisotope in saline with intrinsic activity 74 MBq in 1 ml was used as the marker. Laser application was performed immediately prior to the application of the marker with a tag shower 60 mW probe, emitting 680 nm red light with surface power density of 0.5 J/cm2.Within the tested children the laser application resulted in a significantly increased skin blood flow. Average results in tested group before LLLT are 7.47 ml/100 g/min, after LLLT 11.08 ml/100 g/min.1. LLLT significantly increases the perfusion of the skin. 2. The effect of the increased perfusion as the result of laserotherapy in the most evident in children with skin trophic abnormalities. 3. Results confirmed by clinical observation indicate, that perfusion increase in relation to LLLT takes place with participation of trophic component of skin blood circulation.
- Published
- 2016
11. [The correlation between testosterone levels and C-reactive protein in acute bacterial epididymo-orchitis]
- Author
-
Wiktor, Kępa, Grzegorz, Krzyżanowski, Sonu, Sahni, and Andrzej, Zieliński
- Subjects
Adult ,Aged, 80 and over ,Epididymitis ,Male ,C-Reactive Protein ,Acute Disease ,Humans ,Orchitis ,Testosterone ,Bacterial Infections ,Middle Aged ,Aged - Abstract
Acute bacterial epididymo-orchitis is common urological condition that usually originates from ascending infection of lower urinary tract. It is characterized by infection of testis combined with spermatogenesis and steroidogenesis impairment. There is also a component of local and systemic inflammation.The aim of this study was to assess the effect of systemic inflammation associated with acute epididymo-orchitis on testis steroidogenesis.30 patients with acute bacterial epididymoorchitis treated in our ward without any oncologic involvement or other systemic inflammatory conditions were considered for the study. Total serum levels of testosterone and C-reactive protein measured within 12 hours of admission.Low total testosterone levels regarding to random laboratory population norms were noticed in 11 patients. Diminished serum total testosterone levels regarding to medium age levels were identified in 24 patients (80%). 29 patients had serum CRP levels elevated what gives average 22x fold. There is a statistically significant negative correlation between serum total testosterone levels and CRP serum levels were found (R - 0.75; p0.000002 Spearman's correlation).There is a strong influence of ongoing systemic inflammation caused by bacterial infection on steroidogenesis in testis in acute epididymo-orchitis patients.
- Published
- 2016
12. Chemokine CXCL13 concentration in cerebrospinal fluid in patients with neuroborreliosis--own observations
- Author
-
Lucjan, Kępa, Barbara, Oczko-Grzesik, Barbara, Sobala-Szczygieł, and Anna, Boroń-Kaczmarska
- Subjects
Adult ,Male ,B-Lymphocytes ,Inpatients ,Humans ,Lyme Neuroborreliosis ,Female ,Middle Aged ,Chemokine CXCL13 ,Biomarkers ,Anti-Bacterial Agents ,Cerebrospinal Fluid ,Follow-Up Studies - Abstract
of the study was to evaluate the usefulness of cerebrospinal fluid chemokine CXCL13 concentration assay in diagnostics of neuroborreliosis in adults.Investigations were carried out in 22 patients treated for neuroborreliosis , manifested as lymphocytic meningitis, at the Department of Infectious Diseases, Medical University of Silesia, in Bytom between 2011-2013. Based on the presence or absence of anti-borrelial antibodies in the cerebrospinal fluid, the examined individuals were divided into two groups on the day of admission: group I--patients with antiborrelial antibodies in the cerebrospinal fluid (confirmed diagnosis of neuroborreliosis), group II--patients without antiborrelial antibodies in the cerebrospinal fluid (possible diagnosis of neuroborreliosis). In all patients the cerebrospinal fluid CXCL13 level was assessed on the first day of hospitalization. Control tests were performed in both groups after 14 days of therapy with antibiotics.Mean cerebrospinal fluid CXCL13 concentration in group I on the 1st day was 4123 pg/mL, and in group II--3422 pg/mL. Differences in mean concentrations of this chemokine were statistically insignificant. No correlations between examined mean CXCL13 concentrations and other cerebrospinal fluid inflammatory parameters were revealed. The control tests showed the evident decrease of CXCL13 level in cerebrospinal fluid in both groups. Besides, in individuals of group II anti-Borrelia burgdorferi antibodies appeared in cerebrospinal fluid, whereas in group I, the control results of this parameter were similar to preliminary values.The obtained results indicate a kind of usefulness of estimation of cerebrospinal fluid chemokine CXCL13 concentration in diagnostics of early, acute neuroborreliosis, manifested as lymphocytic meningitis, especially in case of anti-borrelia antibodies absence in cerebrospinal fluid. Changes in this chemokine concentrations, opposite to cerebrospinal fluid levels of anti-borrelia antibodies, may be prognostic in acute, early neuroborreliosis.
- Published
- 2016
13. The epidemiological and clinical analysis of Clostridium difficile infections in patients hospitalized due to the infection at the Department of Infectious Diseases in Bytom
- Author
-
Wojciech, Stolarz, Barbara, Sobala-Szczygieł, Damian, Piotrowski, Lucjan, Kępa, Barbara, Oczko-Grzesik, and Anna, Boroń-Kaczmarska
- Subjects
Adult ,Aged, 80 and over ,Diarrhea ,Male ,Cross Infection ,Clostridioides difficile ,Age Factors ,Middle Aged ,Anti-Bacterial Agents ,Epidemiologic Studies ,Patient Admission ,Clostridium Infections ,Humans ,Female ,Poland ,Aged ,Retrospective Studies - Abstract
Clostridium difficile infections are becoming a more serious problem as hospital-acquired infections and the consequence of common antibiotic therapy, also on an out-patient basis.The aim of the study was the epidemiological and clinical analysis of patients with Clostridium difficile-associated disease (CDAD) at the Clinical Department of Infectious Diseases and Hepatology, Bytom in 2014.A retrospective analysis of the medical documentation of patients with the diagnosis of CDAD was performed. The study group was comprised of 24 patients. The following factors were analysed: gender, age, recent hospitalization, use of proton-pump inhibitors, H2-receptor inhibitors, use of antibiotics, co-morbidities, and the clinical course with consideration given to additional laboratory tests (CRP, creatinine, WBC count).All patients with diagnosed CDAD had been previously hospitalized and 75% of subjects were treated with antibiotics in the period preceding the onset of the disease. Recurrence of the disease was observed in 29% of cases, on average, 12.5 days after hospital discharge. In 16.7% of patients, CDAD resulted in death. Higher CRP concentrations on admission were observed in patients who died compared to the survivors (91.1 mg/l vs. 33.6 mg/l, p=0.015). Additionally, higher concentrations of CRP and leukocytosis were observed in patients with an unfavourable outcome of the disease. Respiratory insufficiency and hypotension were connected with a higher risk of death.Hospitalization, antibiotic therapy, advanced age and co-morbidities may contribute to the occurrence of CDAD. In our study, initially high concentrations of CRP, respiratory insufficiency and hypotension were the predictive factors of a fatal outcome of the disease. The dynamics of changes in the leukocyte value and CRP concentration were of lesser importance.
- Published
- 2016
14. An Activity of Thioacyl Derivatives of 4-Aminoquinolinium Salts towards Biofilm Producing and Planktonic Forms of Coagulase-Negative Staphylococci
- Author
-
Robert D. Wojtyczka, Małgorzata Kępa, Danuta Idzik, Andrzej Zięba, and Arkadiusz Dziedzic
- Subjects
Article Subject ,Microorganism ,Staphylococcus ,lcsh:Medicine ,Microbial Sensitivity Tests ,Biology ,medicine.disease_cause ,Chloride ,General Biochemistry, Genetics and Molecular Biology ,Microbiology ,chemistry.chemical_compound ,medicine ,Humans ,General Immunology and Microbiology ,Quinoline ,lcsh:R ,Biofilm ,General Medicine ,Staphylococcal Infections ,Antimicrobial ,Plankton ,chemistry ,Biofilms ,Aminoquinolines ,Coagulase ,Antibacterial activity ,medicine.drug ,Research Article - Abstract
Microorganisms present in different environments have developed specific mechanisms of settling on various abiotic and biotic surfaces by forming a biofilm. It seems to be well justified to search for new compounds enabling biofilm reduction, which is highly resistant to antibiotics. This study was thus an initial assessment of the antibacterial activity of two new quinoline derivatives of a structure of 3-thioacyl 1-methyl 4-arylaminoquinolinium salts against coagulase-negative staphylococci (CoNS) isolated from a hospital environment, in a form of both biofilms and in planktonic form. Thirty-three stains of CoNS isolated from the hospital environment (air, surfaces) and seven reference strains from the ATCC collection were selected for the study. The mean MIC value for 1-methyl-3-benzoylthio-4-(4-chlorophenylamino)quinolinum chloride (4-chlorophenylamino derivative) was 42.60 ± 19.91 μg/mL, and in the case of strains subjected to 1-methyl-3-benzoylthio-4-(4-fluorophenylamino)quinolinum chloride (4-fluorophenylamino derivative) activity, the mean MIC value was 43.20 ± 14.30 μg/mL. The mean concentration of 4-chlorophenylamino derivative that inhibited biofilm formation was 86.18 ± 30.64 μg/mL. The mean concentration of 4-fluorophenylamino derivatives that inhibited biofilm formation was higher and amounted to 237.09 ± 160.57 μg/mL. Based on the results, both derivatives of the examined compounds exhibit high antimicrobial activity towards strains growing both in planktonic and biofilm form.
- Published
- 2015
15. Cerebrospinal fluid interleukin-6 concentration in patients with purulent, bacterial meningitis - own observations
- Author
-
Lucjan, Kępa, Barbara, Oczko-Grzesik, and Anna, Boroń-Kaczmarska
- Subjects
Adult ,Male ,Interleukin-6 ,Meningoencephalitis ,Humans ,Female ,Middle Aged ,Prognosis ,Severity of Illness Index ,Biomarkers ,Meningitis, Bacterial - Abstract
This study aimed at evaluating the usefulness of determining cerebrospinal fluid (CSF) interleukin-6 (IL-6) concentration in adults with purulent, bacterial meningoencephalitis.A study group consisted of 16 patients hospitalized in the Department of Infectious Diseases of the Medical University of Silesia in Bytom in 2008 - 2012 due to purulent, bacterial meningoencephalitis. All of them were classified into two groups based on clinical severity, assessed on admission: group I - severe condition, group II - moderately severe or mild condition. CSF IL-6 concentration was measured in all patients on the first day of hospitalization.Mean concentrations of IL-6 in CSF were assessed at 391.54 pg/mL and 110.51 pg/mL in patients in severe (group I) and moderately severe or mild condition (group II), respectively. Differences between CSF mean concentrations of this cytokine in both groups were statistically significant (p0.01). No correlations between CSF IL-6 concentrations and other CSF inflammatory parameters were determined. Control testing performed in 5 patients of group I revealed only slight decrease of CSF IL-6 concentration in fatal cases. In case of patients who recovered from disease, IL-6 concentration in CSF was evidently decreased compared to its initial value.Results suggest the usefulness of determining CSF interleukin-6 concentration to estimate inflammation intensity in the subarachnoid space, and indirectly, patient's clinical severity. IL-6 concentration may be also of prognostic importance in purulent, bacterial meningoencephalitis.
- Published
- 2015
16. Pregnancy and pulmonary arterial hypertension: A clinical conundrum
- Author
-
Atul Palkar, Burton Rochelson, Sonu Sahni, Wiktor Kępa, and Arunabh Talwar
- Subjects
Adult ,Pediatrics ,medicine.medical_specialty ,Hypertension, Pulmonary ,Pregnancy, High-Risk ,Vasodilator Agents ,Pregnancy Complications, Cardiovascular ,MEDLINE ,Signs and symptoms ,Disease ,Nitric Oxide ,Young Adult ,Pregnancy ,Internal medicine ,Prenatal Diagnosis ,Internal Medicine ,medicine ,Humans ,Antihypertensive Agents ,International level ,business.industry ,Pregnancy Outcome ,Obstetrics and Gynecology ,Prenatal Care ,medicine.disease ,Delivery, Obstetric ,Pulmonary hypertension ,Hospitalization ,Vasodilation ,Perinatal Care ,medicine.anatomical_structure ,Early Diagnosis ,Vasoconstriction ,Childbearing age ,Cardiology ,Vascular resistance ,Female ,business - Abstract
Pulmonary arterial hypertension (PAH) is a rare and devastating disease characterized by progressive increases in pulmonary arterial pressure and pulmonary vascular resistance which eventually leads to right ventricular failure and death. PAH inflicts most commonly women, majority of who are of childbearing age. Pregnancy in the setting of PAH is absolutely contraindicated due to high maternal fetal morbidity and guidelines do not exist for the management of such cases. A MEDLINE/PubMed search was performed identifying all relevant articles with "pulmonary arterial hypertension" and "pregnancy" in the title. Six case series were reviewed as well as our own center's experience outlined. Though there exists generalized treatment measures that are followed in such cases, management varies among different national centers as well an on an international level. At our center patients are managed using a multidisciplinary approach at a high risk obstetric center with preference for intravenous prostacyclin therapy. Women of child bearing age with possible signs and symptoms of PAH must be promptly diagnosed and managed expectantly with an emphasis on maternal-fetal safety.
- Published
- 2014
17. Gentamicin-containing collagen implant reduces sternal wound complications after cardiac surgery: a retrospective analysis
- Author
-
Michał Krejca, Krzysztof Kępa, and Łukasz J. Krzych
- Subjects
Male ,medicine.medical_specialty ,Sternum ,Multivariate analysis ,Risk Factors ,Medicine ,Humans ,Surgical Wound Infection ,Cardiac Surgical Procedures ,Aged ,Retrospective Studies ,Drug Implants ,Wound Healing ,business.industry ,Standard treatment ,General Medicine ,Antibiotic Prophylaxis ,Middle Aged ,medicine.disease ,Wound infection ,Pulmonary hypertension ,Sternotomy ,Surgery ,Cardiac surgery ,Anti-Bacterial Agents ,Cohort ,Multivariate Analysis ,Gentamicin ,Female ,Collagen ,Gentamicins ,business ,Wound healing ,medicine.drug - Abstract
Introduction : The majority of evidence for use of gentamicin-containing collagen implants (GCCI) demonstrates a positive impact on infection prophylaxis despite the equivocal results of a recently published large-scale study. The primary aim of the study was to evaluate the impact of prophylactic use of GCCI on SWI following cardiac surgery in a routine clinical setting. A secondary aim was to identify the risk factors for SWI among the patient cohort. Methods : A consecutive series of patients who had undergone sternotomy were analysed on a retrospective basis. Patient characteristics, risk factors and procedure-related variables were analysed for Group I (superficial sternal wound infection [SSWI]) and Group II (deep sternal wound infection [DSWI]) in relation to patients with complete wound healing. Results : A total of 1118 patients met the inclusion criteria. The bivariate analysis demonstrated that the SSWI rate was significantly reduced by 43% in the GCCI group vs. standard treatment. Multivariate analysis demonstrated that addition of GCCI to standard treatment reduced the DSWI rate by 59% vs. standard treatment alone. Arterial hypertension, permanent/persistent atrial fibrillation and chest revision were identified as new risk factors for SSWI and pulmonary hypertension and chest revision were identified as new risk factors for DSWI. Discussion : This study confirms the positive results with GCCI seen in the majority of published studies in cardiac surgery. Conclusion : In routine clinical practice the addition of GCCI to standard infection prophylaxis reduces the risk of both SSWI and DSWI in high-risk patients undergoing cardiac surgery.
- Published
- 2014
18. How does gender influence the recognition of cardiovascular risk and adherence to self : care recommendations? : a study in polish primary care
- Author
-
Ireneusz Szymczyk, Witold Lukas, Teresa Pawlikowska, Ewa Wojtyna, and Joanna Kępa
- Subjects
Gerontology ,Adult ,Male ,Risk ,Coping (psychology) ,medicine.medical_specialty ,Health Knowledge, Attitudes, Practice ,Primary care ,Disease ,Stress ,Cohort Studies ,Cognition ,Sex Factors ,RA0421 ,Surveys and Questionnaires ,Health care ,Lifestyle intervention ,Adaptation, Psychological ,medicine ,Humans ,Longitudinal Studies ,Psychiatry ,Health behavior ,Aged ,Motivation ,Primary Health Care ,business.industry ,Age Factors ,Gender ,Feeding Behavior ,Middle Aged ,Cardiovascular risk ,Self Care ,Adherence ,Cardiovascular Diseases ,Self care ,Patient Compliance ,Female ,Poland ,Coping ,business ,Family Practice ,Risk Reduction Behavior ,RA ,Stress, Psychological ,Cognitive appraisal ,Research Article - Abstract
Background Studies have shown a correlation between gender and an ability to change lifestyle to reduce the risk of disease. However, the results of these studies are ambiguous, especially where a healthy lifestyle is concerned. Additionally, health behaviors are strongly modified by culture and the environment. Psychological factors also substantially affect engagement with disease-related lifestyle interventions. This study aimed to examine whether there are differences between men and women in the frequency of health care behavior for the purpose of reducing cardiovascular risk (CVR), as well as cognitive appraisal of this type of risk. We also aimed to identify the psychological predictors of engaging in recommended behavior for reducing the risk of cardiovascular disease after providing information about this risk in men and women. Methods A total of 134 consecutive eligible patients in a family practice entered a longitudinal study. At initial consultation, the individual’s CVR and associated health burden was examined, and preventive measures were recommended by the physician. Self-care behavior, cognitive appraisal of risk, and coping styles were then assessed using psychological questionnaires. Six months after the initial data collection, the frequency of subjects’ self-care behavior was examined. Results We found an increase in health care behavior after providing information regarding the rate of CVR in both sexes; this increase was greater for women than for men. Women followed self-care guidelines more often than men, particularly for preventive measures and dietary advice. Women were more inclined to recognize their CVR as a challenge. Coping style, cognitive appraisal, age, level of health behaviors at baseline and CVR values accounted for 48% of the variance in adherence to self-care guidelines in women and it was 52% in men. In women, total risk of CVD values were most important, while in men, cognitive appraisal of harm/loss was most important. Conclusions Different predictors of acquisition of health behavior are encountered in men and women. Our results suggest that gender-adjusted motivation models influencing the recognition process need to be considered to optimize compliance in patients with CVR.
- Published
- 2013
19. Catechin Hydrate Augments the Antibacterial Action of Selected Antibiotics against Staphylococcus aureus Clinical Strains
- Author
-
Tomasz J. Wąsik, Maria Miklasińska, Małgorzata Kępa, Robert D. Wojtyczka, Danuta Idzik, and Arkadiusz Dziedzic
- Subjects
Methicillin-Resistant Staphylococcus aureus ,0301 basic medicine ,catechin hydrate ,Staphylococcus aureus ,medicine.drug_class ,030106 microbiology ,Antibiotics ,Pharmaceutical Science ,Microbial Sensitivity Tests ,medicine.disease_cause ,Staphylococcal infections ,Article ,Catechin ,Analytical Chemistry ,Microbiology ,lcsh:QD241-441 ,03 medical and health sciences ,lcsh:Organic chemistry ,antibacterial activity ,Vancomycin ,Drug Discovery ,medicine ,Humans ,Physical and Theoretical Chemistry ,Chemistry ,Clindamycin ,Organic Chemistry ,Drug Synergism ,Staphylococcal Infections ,Antimicrobial ,medicine.disease ,Methicillin-resistant Staphylococcus aureus ,Anti-Bacterial Agents ,Chemistry (miscellaneous) ,Molecular Medicine ,Antibacterial activity ,medicine.drug - Abstract
Synergistic effects between commonly used antibiotics and natural substances may be an alternative to conventional antibacterial therapies. The objective of the presented study was to assess the in vitro antibacterial activity of catechin hydrate (CH) and evaluate the interactions of CH with selected antibiotics using Staphylococcus aureus clinical and reference strains. CH displayed diverse activity towards examined S. aureus strains, with minimal inhibitory concentrations (MICs) ranging from 256 to 2048 µg/mL. The interaction between CH and antibiotics was assessed by an E-test. The most significant synergistic effects were noticed for CH in combination with clindamycin and erythromycin. For cefoxitin and vancomycin a decrease of MIC values in the presence of CH was also observed, but it did not reach statistical significance. The obtained results demonstrate that CH shows antimicrobial activity against Staphylococcus aureus clinical strains. What is more, we proved a synergistic effect of CH with erythromycin and clindamycin.
- Published
- 2016
20. Analysis of mercury levels in historical bone material from syphilitic subjects : pilot studies (short report)
- Author
-
Alicja Drozd, H. Glab, Beata Stepańczak, Stanisław Walas, Krzysztof Szostek, Tomasz Kozłowski, Małgorzata Kępa, Małgorzata Grupa, and Halina Mrowiec
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pediatrics ,mercury ,syphilis ,chemistry.chemical_element ,Mercury fumes ,Pilot Projects ,History, 18th Century ,Tertiary Syphilis ,Bone and Bones ,Mass Spectrometry ,Anthropology, Physical ,History, 17th Century ,historical bone ,la-icp-ms technique ,Bone material ,medicine ,Humans ,Cemeteries ,Contact method ,Syphilis ,Ecology, Evolution, Behavior and Systematics ,History, 15th Century ,business.industry ,History, 19th Century ,Mercury ,General Medicine ,Middle Aged ,medicine.disease ,History, Medieval ,Mercury (element) ,Surgery ,Archaeology ,chemistry ,History, 16th Century ,Anthropology ,Healthy individuals ,Female ,Animal Science and Zoology ,Poland ,Leprosy ,business - Abstract
The aim of the present work is to study the remains of seven individuals with typical symptoms of tertiary syphilis in terms of mercury content in bones, thereby verifying whether they were subjected to treatment and, if they were, how long their organisms were exposed to toxic mercury fumes. Mercury was used, mainly in the Middle Ages and in the early modern period, as a preventive measure in case of individuals suffering from syphilis, a venereal disease, and also leprosy. Syphilitic patients treated this way should demonstrate increased concentration of mercury in their bones. The skeletons studied in the present work originate from various archaeological sites in southern and north-central Poland. The analyses concerned individuals with diagnosed syphilis as well as healthy individuals who constituted the control group. The analyses were performed by the LA-ICP-MS technique, with the use of laser Nd: YAG, Macro, 266 nm, New Wave, USA, coupled with Spectrometer Elan DRC-e Perkin Elmer, USA. The content analysis of the studied bone material revealed with high probability that the contact method of mercurial treatment was used only in the case of two women from north-central Poland, deceased at the turn of the 15th century at the earliest.
- Published
- 2012
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.